Even subtle differences in the wording of social media messages may be enough to sway young people’s beliefs about depression and anxiety and their treatment.
Esketamine Also Effective Without Adjunctive Antidepressant
Esketamine nasal spray (Spravato) monotherapy was helpful in improving symptoms of treatment-resistant depression, a randomized, double-blind trial found. Among 379 participants in the efficacy analysis,
November 5, 2024